Uni-Logo
ZHG-Logo
Zentrum für Humangenetik Bremen

Universität Bremen, Leobener Str. ZHG, D-28359 Bremen




Wir über uns Mitarbeiter Kontakt Genetische Beratung Diagnostik Forschung Publikationen Lehre Schulen
News Links Home Haftungsausschluss Impressum Research Disclaimer                
   

Publikationen
Archiv



2009
  • Bullerdiek J, Helmke BM (2009). Comment on 'HMGA2, MicroRNAs, and Stem Cell Aging'. Cell Online Comment

  • Fehr A, Meyer A, Heidorn K, Röser K, Löning T, Bullerdiek J (2009). A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma. Genes Chromosomes Cancer 48:777-785.

  • Fehr A, Stenman G, Bullerdiek J, Löning T (2009). Molecular markers in salivary gland tumors: Their use in diagnostic and prognostic workup. Pathologe 30:466-471.

  • Gentschev I, Stritzker J, Hofmann E, Weibel S, Yu YA, Chen N, Zhang Q, Bullerdiek J, Nolte I, Szalay AA (2009)(online 2008). Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther 16:320-328.
  • Hauschild G, Muschter N, Richter A, Ahrens H, Gosheger G, Fehr M, Bullerdiek J (2009). Cartilage replacement in dogs. Vet Comp Orthop Traumatol 22:216-221.

  • Klemke M, Meyer A, Hashemi Nezhad M, Bartnitzke S, Drieschner N, Frantzen C, Schmidt E-H, Belge G, Bullerdiek J (2009)(online 2008). Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease. Genes Chromosomes Cancer 48:171-178.
  • Lacbawan F, Solomon BD, Roessler E, El-Jaick K, Domené S, Vélez JI, Zhou N, Hadley D, Balog JZ, Long R, Fryer A, Smith W, Omar S, McLean SD, Clarkson K, Lichty A, Clegg NJ, Delgado MR, Levey E, Stashinko E, Potocki L, Vanallen MI, Clayton-Smith J, Donnai D, Bianchi DW, Juliusson PB, Njølstad PR, Brunner HG, Carey JC, Hehr U, Müsebeck J, Wieacker PF, Postra A, Hennekam RC, van den Boogaard MJ, van Haeringen A, Paulussen A, Herbergs J, Schrander-Stumpel CT, Janecke AR, Chitayat D, Hahn J, McDonald-McGinn DM, Zackai EH, Dobyns WB, Muenke M (2009). Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function. J Med Genet 46:389-398.

  • Mohamed SA, Sievers HH, Hanke T, Richardt D, Schmidtke C, Charitos EI, Belge G, Bullerdiek J (2009). Pathway analysis of differentially expressed genes in patients with acute aortic dissection. Biomark Insights 4:81-90.

  • Pavlova A, Brondke H, Müsebeck J, Pollmann H, Srivastava A, Oldenburg J (2009). Molecular mechanisms underlying hemophilia A phenotype in seven females. J Thromb Haemost 7:976-982.

  • Petersen S, Soller JT, Wagner S, Richter A, Bullerdiek J, Nolte I, Barcikowski S, Murua Escobar H (2009). Co-transfection of plasmid DNA and laser-generated gold nanoparticles does not disturb the bioactivity of  GFP-HMGB1 fusion protein. J Nanobiotechnology 7:6.

  • Richter A, Hauschild G, Murua Escobar H, Nolte I, Bullerdiek J (2009)(online 2008). Application of high-mobility-group-A proteins increases the proliferative activity of chondrocytes in vitro. Tissue Eng  Part A 15:473-477.

  • Sterenczak KA, Willenbrock S, Barann M, Klemke M, Soller JT, Eberle N, Nolte I, Bullerdiek J, Murua Escobar H (2009)(online 2008). Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene 434:35-42.

  • Verdorfer I, Fehr A, Bullerdiek J, Scholz N, Brunner A, Krugmann J, Hager M, Haufe H, Mikuz G, Scholtz A (2009). Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland. Oncol Rep 22:305-11.

  • Winter N, Meyer A, Richter A, Krisponeit D, Bullerdiek J (2009). Elevated levels of HMGB! in cancerous and inflammatory effusions. Anticancer Res 29:5013-5017.

2008  
  • Altmann S, Lange S, Pommerencke J, Murua Escobar H, Bullerdiek J, Nolte I, Freund M, Junghanss C (2008). High Mobility Group Box 1-Protein expression in canine haematopoietic cells and influence on canine peripheral blood mononuclear cell proliferative activity. Vet Immunol Immunopathol 126:367-372.
  • Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J (2008).Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 47:56-63.

  • Beuing C, Soller JT, Muth M, Wagner S, Dolf G, Schelling C, Richter A, Willenbrock S, Reimann-Berg N, Winkler S, Nolte I, Bullerdiek J, Murua Escobar H (2008). Genomic characterisation, chromosomal assignment and in vivo localisation of the canine high mobility group A1 (HMGA1) gene. BMC Genet 9:49.
  • Fehr A, Röser K, Heidorn K, Hallas C, Löning T, Bullerdiek J (2008). A new type of MAML2 fusion in mucoepidermoid carcinoma. Genes Chromosomes Cancer 47:203-206.

  • Fehr A, Röser K, Belge G, Löning T, Bullerdiek J (2008). A closer look at Warthin tumors and the t(11;19). Cancer Genet Cytogenet 180:135-139.

  • Fork MAM, Murua Escobar H, Soller JT, Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N, Hedrich HHJ, Bullerdiek J, Nolte I (2008). Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC Cancer 8:240.

  • Hafner C, Vogt T, Landthaler M, Müsebeck J (2008). FGFR3 and PIK3CA mutations are present in familial seborrheic keratoses. Br J Dermatol 159: 214-217.
  • Meyer A, Staratschek-Jox A, Springwald A, Wenk H, Wolf J, Wickenhauser C, Bullerdiek J (2008). Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1. Leuk Lymphoma 49:1184-1189.

  • Reimann-Berg N, Murua Escobar H, Nolte I, Bullerdiek J (2008). Testicular tumor in an XXY dog. Cancer Genet Cytogenet 183:114-116. 

  • Soller JT, Beuing C, Murua Escobar H, Winkler S, Reimann-Berg N, Drieschner N, Dolf G, Schelling C, Nolte I, Bullerdiek J (2008).Chromosomal assignment of canine THADA gene to CFA 10q25.Mol Cytogenet 1:11.
  • Von Ahsen I, Nimzyk R, Klemke M, Bullerdiek J (2008). A microRNA encoded in a highly conserved part of the mammalian HMGA2 gene. Cancer Genet Cytogenet 187:43-44.

  • Winter N, Neumann A, Bullerdiek J (2008). Cell-free DNA in amniotic fluid remains to be attached to HMGA2 - implications for non-invasive prenatal diagnosis. Prenat Diagn 28:1126-1130.


2007
  • Drieschner N, Kerschling S, Soller JT, Rippe V, Belge G, Bullerdiek J, Nimzyk R (2007). A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas. Gene 403:110-117.

  • Jensen J, Simon D, Murua Escobar H, Soller JT, Bullerdiek J, Beelitz P, Pfister K, Nolte I (2007). Anaplasma phagocytophilum in dogs in Germany. Zoonoses Public Health 54:94-101.

  • Meyer B, Krisponeit D, Junghanss C, Murua Escobar H, Bullerdiek J (2007). Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: Correlation between HMGA2 expression and white blood cell count. Leuk Lymphoma 48:2008-2013.

  • Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, Vollmer E, Bullerdiek J (2007). HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog 46:503-511.

  • Ostersehlt D, Rippe V (2007). Drei Spritzen gegen Krebs. Unterrichtsmodell Sekundarstufe I/II Unterricht Biologie 330: 37-44.

  • Soller JT, Murua Escobar H, Willenbrock S, Janssen M, Eberle N, Bullerdiek J., Nolte I (2007). Comparison of the human and canine cytokines IL-1(α/ß) and TNF-α to orthologous other mammalians. J Heredity 98:485-490.

  • Winkler S, Murua Escobar H, Meyer B, Simon D, Eberle N, Baumgartner W, Loeschke S, Nolte I, Bullerdiek J (2007). HMGA2 expression in a canine model of prostate cancer. Cancer Genet Cytogenet 177:98-102.

2006
  • Bullerdiek J (2006). Moderne Methoden in der Genomforschung und Humangenetik (Research into the human genome driven by improved methods). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:989-994.

  • Drieschner N, Belge G, Rippe V, Meiboom M, Loeschke S, Bullerdiek J (2006). Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. Thyroid 16:1091-1096.

  • Murua Escobar H, Soller JT, Sterenczak KA, Sperveslage JD, Schlueter C, Burchardt B, Eberle N, Fork M, Nimzyk R, Winkler S, Nolte I, Bullerdiek J (2006). Cloning and characterization of the canine receptor for advanced glycation end products. Gene 369:45-52.

  • Rooryck C, Roudaut C, Robine E, Müsebeck J, Arveiler B (2006). Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient. Pigment Cell Res 19:239-242.

  • Soller JT, Murua Escobar H, Janssen M, Fork M, Bullerdiek J, Nolte I (2006). Cytokine genes single nucleotide polymorphism (SNP) screening analyses in canine malignant histiocytosis. Anticancer Res 26:3417-3420.

  • Von Ahsen I, Rogalla P, Bullerdiek J (2006). Germ line mutations of the HMGA2 gene are rare among the general population. Anticancer Res 26:3289-3292.

  • Winkler S, Reimann-Berg N, Murua Escobar H, Loeschke S, Eberle N, Höinghaus R, Nolte I, Bullerdiek J (2006). Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer. Cancer Genet Cytogenet 169:154-158.
                                                                                      
                                                                                             
2005
  • Bauer T, Rubehn B, Ostendorf A, Chichkov BN, Bullerdiek J, Nolte I, Hauschild G (2005). Generation of three-dimensional polymeric micro-structures for surface vitalization by Two-Photon-Polymerization. Proc 6th Int Symp Laser Precision Microfabrication (LPM2005)1:1-4.

  • Hauke S, Leopold S, Schlueter C, Flohr AM, Murua Escobar H, Rogalla P, Bullerdiek J (2005). Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene. Biochim Biophys Acta 1729:24-31.

  • Kuechler A, Ziegler M, Blank C, Rommel B, Bullerdiek J, Ahrens J, Claussen U, Liehr T (2005). A highly complex chromosomal rearrangement between five chromosomes in a healthy female diagnosed in preparation for intracytoplasmatic sperm injection. J Histochem Cytochem 53:355-357.

  • Martins C, Fonseca I, Roque L, Pereira T, Ribeiro C, Bullerdiek J, Soares J (2005). PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod Pathol 18:1048-1055.

  • Mohamed SA, Hanke T, Schlueter C, Bullerdiek J, Sievers HH (2005). Ubiquitin fusion degradation 1-like gene dysregulation in bicuspid aortic valve. J Thorac Cardiovasc Surg 130:1531-1536.

  • Murua Escobar H, Soller JT, Richter A, Meyer B, Winkler S, Bullerdiek J, Nolte I (2005). “Best friends” sharing the HMGA1 Gene: Comparison of the human and canine HMGA1 to orthologous other species. J Heredity 96:777-781.

  • Richter A, Murua Escobar H, Günther K, Soller JT, Winkler S, Nolte I, Bullerdiek J (2005). RAS-gene hot-spot mutations in canine neoplasias. J Heredity 96:764-765.

  • Röser K, Jäkel KT, Bullerdiek J, Löning T. (2005). Bedeutung molekular-zytogenetischer Befunde bei Speicheldrüsentumoren am Beispiel des Mukoepidermoidkarzinoms. Pathologe 26:359-366.

  • Schlueter C, Hauke S, Loeschke S, Wenk HH, Bullerdiek J (2005). HMGA1 proteins in human atherosclerotic plaques. Pathol Res Pract 201:101-107.

  • Schlueter C, Weber H, Meyer B, Rogalla P, Röser K, Hauke S, Bullerdiek J (2005). Angiogenetic signaling through hypoxia: HMGB1: An angiogenetic switch molecule. Am J Pathol 166:1259-1263.

  • von Ahsen I, Rogalla P, Bullerdiek J (2005). Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15). Cancer Genet Cytogenet 163:68-70.

  • Winkler S, Murua Escobar H, Eberle N, Reimann-Berg N, Nolte I, Bullerdiek J (2005). Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype.J Hered 96:782-785.

  • Winkler S, Murua Escobar H, Reimann-Berg N, Bullerdiek J, Nolte, I. (2005). Cytogenetic investigations in four canine lymphomas. Anticancer Res 25:3995-3998.

  • Zorn-Kruppa M, Tykhonova S, Belge G, Bednarz J, Diehl HA, Engelke M (2005). A human corneal equivalent constructed from SV40-immortalised corneal cell lines. Altern Lab Anim 33:37-45.


2004
  • Chan JKC, Hirokawa M, Evans H, Williams ED, Osamura Y, Cady B, Sabrinho-Simoes M, Derwahl M, Paschke R, Belge G, Oriola J, Studer H, Eng C, Asa SL, Lloyd RV, Baloch Z, Ghossein R, Mazzaferri E, Fagin JA (2004). Follicular adenoma. pp:98-103. In: DeLellis R, Heitz P, Lloyd R, Eng C (Hrsg.): WHO classification of tumors. Pathology and genetics of tumors of endocrine organs. IARC Press, Lyon

  • Goldmann T, Flohr AM, Murua Escobar H, Gerstmayer B, Janssen U, Bosio A, Loeschke S, Vollmer E, Bullerdiek J (2004). The HOPE-technique permits Northern blot and microarray analyses in paraffin-embedded tissues. Pathol Res Pract 200:511-515.

  • Meiboom M, Murua Escobar H, Winkler S, Nolte I, Bullerdiek J (2004). Molecular characterization and mapping of the canine KRAB zinc finger gene ZNF331. Anim Genet 35:262-263.

  • Meyer B, Murua Escobar H, Hauke S, Richter A, Winkler S, Rogalla P, Flohr AM, Bullerdiek J, Nolte I (2004). Expression pattern of the HMGB1 gene in sarcomas of the dog. Anticancer Res 24:707-710.

  • Meyer B, Murua Escobar H, Winkler S, Dolf G, Schelling C, Bullerdiek J, Nolte I (2004). Molecular characterisation and mapping of the canine Cyclin D1 (CCND1). Anim Genet 35:413.

  • Meyer J, Murua Escobar H, Bartnitzke S, Schelling C, Dolf G, Nolte I, Bullerdiek J (2004). The FAS-activated serine/threonine kinase gene (FASTK) maps to canine chromosome 16. Anim Genet 35:497.

  • Murua Escobar H, Günther K, Richter A, Soller JT, Winkler S, Nolte I, Bullerdiek J (2004). Absence of ras-gene hotspot mutations in canine fibrosarcomas and melanomas. Anticancer Res 24:3027-3028.

  • Murua Escobar H, Meyer J, Winkler S, Schelling C, Dolf G, Nolte I, Bullerdiek J (2004). The protein kinase B, gamma (AKT3) gene maps to canine chromosome 7. Anim Genet 35:354-355.

  • Murua Escobar H, Soller JT, Richter A, Meyer B, Winkler S, Flohr AM, Nolte I, Bullerdiek J. (2004). The canine HMGA1. Gene 330:93-99.

  • Richter A, Murua Escobar H, Günther K, Meyer B, Winkler S, Dolf G, Schelling C, Nolte I, Bullerdiek J (2004). The canine NRAS gene maps to CFA 17. Anim Genet 35:355-356.

  • Santos SE, Murua Escobar H, Sider LH, Winkler S, Aoki SM, Milazzotto MP, Campagnari F, Vannucchi CI, Bullerdiek J, Nolte I, Garcia JF (2004). DNA sequence, polymorphism, and mapping of luteinizing hormone receptor fragment (LHCGR) gene in Great Dane dogs. Anim Genet 35:74-75.

  • Tzschach A, Hoeltzenbein M , Bache I, Tinschert S, Bommer C, Körner H, Thiel G, Müsebeck J, Grimm T, Henn E, Brude E, Krüger M, Leube B, Schulze B, Schwanitz G, Raff R, Dufke A, Wolff G, Latos-Bielenska A, Ebner S, Kossakiewicz M, Fuchs S, Barbi G, Köhler A, Wand D (2004). Late-onset diseases among carriers of balanced chromosome rearrangements – results of a multicentre survey. Eur J Hum Genet 12:133-134.

  • Winkler S, Murua Escobar H, Günther K, Richter A, Dolf G, S.chelling C, Bullerdiek J, Nolte I (2004). The canine KRAS2 gene maps to chromosome 22. Anim Genet 35:350-351.

  • Zorn-Kruppa M, Tykhonova S, Belge G, Diehl HA, Engelke M (2004). Comparison of human corneal cell cultures in cytotoxicity testing. ALTEX 21:129-134.

2003
  • Bamberger A-M, Makrigiannakis A, Röser K, Radde J, Karstens T, Flohr AM, Bamberger CM, Bullerdiek J, Löning T (2003). Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue. Virchows Archiv 443:649-654.

  • Becker K, Murua Escobar H, Richter A, Meyer B, Nolte I, Bullerdiek J (2003). The canine HMGA1 gene maps to CFA 23. Anim Genet 34:68-69.

  • Borrmann L, Schwanbeck R, Heyduk T, Seebeck B, Rogalla P, Bullerdiek J, Wisniewski JR (2003). High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucl Acids Res 31:6841-6851.

  • Borrmann L, Seebeck B, Rogalla P, Bullerdiek J (2003). The human HMGA2 promoter is regulated by a polymorphic dinucleotide (TC)-repeat. Oncogene 22:756-760.

  • Flohr AM, Hackenbeck T, Schlüter C, Rogalla P, Bullerdiek J (2003). DNase I treatment of cDNA first-strands prevents RT-PCR amplification of contaminating DNA sequences. BioTechniques 35:920-922, 924, 926.

  • Flohr, AM, Rogalla P, Bonk U, Puettmann B, Buerger H, Gohla G, Packeisen J, Wosniok W, Loeschke S, Bullerdiek J (2003). High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol Histopathol 18:999-1004.

  • Gross KL, Neskey D, Manchanda N, Weremowicz S, Kleinman MS, Nowak RA, Ligon AH, Rogalla P, Drechsler K, Bullerdiek J, Morton CC (2003). HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 38:68-79.

  • Kayser K, Dunnwald D, Kazmierczak B, Bullerdiek J, Kaltner H, Zick Y, Andre S, Gabius HJ (2003). Chromosomal aberrations, profiles of expression of growth-related markers including galectins and environmental hazards in relation to the incidence of chondroid pulmonary hamartomas. Pathol Res Pract 199:589-598.

  • Liehr T, Ziegler M, Starke H, Heller A, Kuechler A, Kittner G, Beensen V, Seidel J, Hässler H, Müsebeck J, Claussen (2003). Conspicuous GTG-banding results of the centromere-near region can be caused by alphoid DNA heteromorphism. Clin Genet 64:166-167.

  • Meiboom M, Belge G, Bol S, El-Aouni C, Schoenmakers EF, Bullerdiek J (2003). Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases. Cancer Genet Cytogenet 146:70-72.

  • Meiboom M, Murua Escobar H, Pentimalli F, Fusco A, Belge G, Bullerdiek J (2003). A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas. Cytogenet Genome Res 101:113-117.

  • Murua Escobar H, Meyer B, Richter A, Becker K, Flohr AM, Bullerdiek J, Nolte I (2003). Molecular characterization of the canine HMGB1. Cytogenet Genome Res 101:33-38.

  • Rippe V, Drieschner N, Meiboom M, Murua Escobar H, Bonk U, Belge G, Bullerdiek J (2003). Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 22:6111-6114.

  • Schlueter C, Hauke S, Flohr AM, Rogalla P, Bullerdiek J (2003). Tissue specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing? Biochim Biophys Acta 1630:1-6.

2002
  • Bullerdiek J (2002). Tumorzytogenetische und molekulargenetische Befunde bei soliden benignen Tumoren. Med Genet 14:135-138.

  • Hauke S, Flohr AM, Rogalla P, Bullerdiek J (2002). Sequencing of intron 3 of HMGIC reveals the existence of a novel exon of that gene. Genes Chromosomes Cancer 34:17-23.

  • Lemke I, Rogalla P, Grundmann F, Kunze W-P, Haupt R, Bullerdiek J (2002). Expression of the HMGA2-LPP fusion transcript in only 1 of 61 karyotypically normal pulmonary chondroid hamartomas. Cancer Genet Cytogenet 138:160-164.

  • Rogalla P, Lemke I, Bullerdiek J (2002). Absence of the HMGIC-LHFP fusion in pulmonary chondroid hamartomas with aberrations involving chromosomal regions 12q13-15 and 13q12-14. Cancer Genet Cytogenet 133:90-93.

  • Rogalla P, Helbig R, Drieschner N, Krohn M, Bullerdiek J (2002). Molecular-cytogenetic analysis of fragmentation of chromosome 17 in the breast cancer cell line EFM-19. Anticancer Res 22:1987-1992.

  • Röijer E, Nordkvist A, Ström AK, Ryd W, Behrendt M, Bullerdiek J, Mark J, Stenman G (2002). Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am J Pathol 160:433-440.

  • Vockerodt M, Belge G, Kube D, Irsch J, Siebert R, Tesch H, Diehl V, Wolf J, Bullerdiek J, Staratschek-Jox A (2002). An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591. Brit J Haematol 119:640-646.

2001
  • Belge G, Rippe V, Meiboom M, Drieschner N, Garcia E, Bullerdiek J (2001). Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations. Cytogenet Cell Genet 93:48-51.

  • Blank C, Schoenmakers, EFPM, Rogalla P, Huys ELPG., Van Rijk AAF, Drieschner N, Bullerdiek, J (2001). Intragenic breakpoint within Rad51L1 in a t(6;14)(p21.3;q24) of a pulmonary chondroid hamartoma. Cytogenet Cell Genet 95:17-19.

  • Bol S, Belge G, Rippe V, Bullerdiek J (2001). Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb. Cytogenet Cell Genet 95:189-191.

  • Bol S, Belge G, Thode B, Bonk U, Bartnitzke S, Bullerdiek J (2001). Cytogenetic tetraclonality in a rare spindle cell variant of an anaplastic carcinoma of the thyroid. Cancer Genet Cytogenet 125:1663-16.

  • Borrmann L, Kim I, Schultheiss D, Rogalla P, Bullerdiek J (2001). Regulation of the expression of HMG1, a co-activator of the estrogen receptor. Anticancer Res 21:301-305.

  • Borrmann L, Wilkening S, Bullerdiek J (2001). The expression of HMGA genes is regulated by their 3'UTR. Oncogene 20:4537-4541.

  • Flohr A M, Rogalla P, Meiboom M, Borrmann L, Krohn M, Thode-Halle B, Bullerdiek J (2001). Variation of HMGB1 expression in breast cancer. Anticancer Res. 21: 3881-3885.

  • Hauke S, Rippe V, Bullerdiek J (2001). Chromosomal rearrangements leading to abnormal splicing within intron 4 of HMGIC? Genes Chromosomes Cancer 30:302-304.

  • Lemke I, Rogalla P, Bullerdiek J (2001). A novel LPP fusion gene indicates the crucial role of truncated LPP proteins in lipomas and pulmonary chondroid hamartomas. Cytogenet Cell Genet 95: 153-156.

  • Lemke I, Rogalla P, Bullerdiek J (2001). Large deletion of part of the HMGIC locus accompanying a t(3;12)(q27-q28;q14-q15) in a lipoma. Cancer Genet Cytogenet 129:161-164.

  • Murua Escobar H, Becker K, Bullerdiek J, Nolte I (2001). The canine ERBB2 gene maps to a chromosomal region frequently affected by aberrations in tumors of the dog (Canis familiaris). Cytogenet Cell Genet 94: 194-195.

  • Piekielko A, Drung A, Rogalla P, Schwanbeck R, Heyduk T, Gerharz M, Bullerdiek J, Wisniewski JR (2001). Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J Biol Chem 276:1984-1992.

  • Rogalla P, Blank C, Helbig R, Wosniok W, Bullerdiek J (2001). Significant correlation between the breakpoints of rare clonal aberrations in benign solid tumors and the assignment of HMGIY retropseudogenes. Cancer Genet Cytogenet 130:51-56.

  • Staratschek-Jox A, Thomas RK, Zander T, Massoudi N, Kornacker M, Bullerdiek J, Fonatsch C, Diehl V, Wolf J (2001). Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236. Br J Cancer 84:381-387.

2000
  • Behrends S, Vehse K, Scholz H, Bullerdiek J, Kazmierczak B (2000). Assignment of GUCY1A3, a candidate gene for hypertension, to human chromosome bands 4q31.1-->q31.2 by in situ hybridization. Cytogenet Cell Genet 88:204-205.

  • Blank C, Rogalla P, Tran KH, Bullerdiek J (2000). A novel high mobility group protein gene is a candidate for Xp22 abnormalities in uterine leiomyomas and other benign tumors. Cancer Genet Cytogenet 121:172-180.

  • Hennig Y, Löschke S, Katenkamp D, Bartnitzke S, Bullerdiek J (2000). A malignant triton tumor with an unbalanced translocation (1;13)(q10;q10) and an isochromosome (8)(q10) as the sole karyotypic abnormalities. Cancer Genet Cytogenet 118:80-82.

  • Kazmierczak B, Dal Cin P, Rogalla P, Van den Berghe H, Bullerdiek J (2000). Regional fine mapping of HMG17 to chromosomal band 1p35. Cancer Genet Cytogenet 116:164-165.

  • Rogalla P, Kazmierczak B, Flohr AM, Hauke S, Bullerdiek J (2000). Back to the roots of a new exon--the molecular archaeology of a SP100 splice variant. Genomics 63:117-122.

  • Rogalla P, Lemke I, Kazmierczak B, Bullerdiek J (2000). An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15). Genes Chromosomes Cancer 29:363-366.

  • Santulli B, Kazmierczak B, Napolitano R, Caliendo I, Chiappetta G, Rippe V, Bullerdiek J , Fusco A (2000). A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia. Cancer Genet Cytogenet 119:70-73.

  • Schwanbeck R, Gerharz M, Drung A, Rogalla P, Piekielko A, Blank C, Bullerdiek J, Wisniewski J (2000). Point mutations within AT-hook domains of the HMGI homologue HMGIYL1 affect binding to gene promoter but not to four-way junction DNA. Biochemistry 39:14419-14425.

  • Spranger S, Rommel B, Jauch A, Bodammer R, Mehl B, Bullerdiek J (2000). Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation. Am J Med Genet 93:107-109.

  • Staratschek-Jox A, Kotkowski S, Belge G, Rüdiger T, Bullerdiek J, Diehl V, Wolf J (2000). Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments inLatent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease. Am J Pathol 156:209-216.

  • Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P, Bullerdiek J, Giancotti V, Van den Berghe H, Dal Cin P (2000). HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 80:359-369.

1999
  • Behrends S, Kazmierczak B, Steenpass A, Knauf B, Bullerdiek J, Scholz H, Eiberg H (1999). Assignment of GUCY1B2, the gene coding for the beta2 subunit of human guanylyl cyclase to chromosomal band 13q14.3 between markers D13S168 and D13S155. Genomics 55:126-127.

  • Bol S, Belge G, Thode B, Bartnitzke S, Bullerdiek J (1999). Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature. Cancer Genet Cytogenet 114:75-77.

  • Breen M, Bullerdiek J, Langford CF (1999). The DAPI banded karyotype of the domestic dog (Canis familiaris) generated using chromosome-specific paint probes. Chromosome Res 7:401-406.

  • Bullerdiek J, Rommel B (1999). Diagnostic and molecular implications of specific chromosomal translocations in mesenchymal tumors. Histol Histopathol 14:1165-1173.

  • Bullerdiek J (1999). Leiomyoma--do viruses play the main role? Genes Chromosomes Cancer 26:181.

  • Dal Cin P, Fusco A, Belge G, Chiappetta G, Fedele M, Pauwels P, Bullerdiek J, Van den Berghe H (1999). Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid. Genes Chromosomes Cancer 24:286-289.

  • Hennig Y, Caselitz J, Stern C, Bartnitzke S, Bullerdiek J (1999). Karyotype evolution in a case of uterine angioleiomyoma. Cancer Genet Cytogenet 108:79-80.

  • Hennig Y, Deichert U, Bonk U, Thode B, Bartnitzke S, Bullerdiek J (1999). Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells.  Mol Hum Reprod 5:1150-1154.

  • Hörsting N, Wohlsein P, Reimann N, Bartnitzke S, Bullerdiek J, Nolte I (1999). Cytogenetic analysis of three oropharyngeal malignant melanomas in dogs. Res Vet Sci 67:149-151.

  • Kazmierczak B, Borrmann L, Bullerdiek J (1999). Assignment of a new gene (LBH). Genomics 56:136-137.

  • Kazmierczak B, Dal Cin P, Meyer-Bolte K, Van den Berghe H, Bullerdiek J (1999). HMG1 is not rearranged by 13q12 aberrations in lipomas. Genes Chromosomes Cancer 24:290-292.

  • Kazmierczak B, Dal Cin P, Sciot R, Van den Berghe H, Bullerdiek J (1999). Inflammatory myofibroblastic tumor with HMGIC rearrangement. Cancer Genet Cytogenet 112:156-160.

  • Kazmierczak B, Kayser K, Meyer-Bolte K, Thode E, Bullerdiek J (1999). Results of cytogenetic analyses on 317 pulmonary chondroid hamartomas point to their pathogenesis. E J Pathol 5(4).

  • Kazmierczak B, Meyer-Bolte K, Tran KH, Wöckel W, Breightman I, Rosigkeit J, Bartnitzke S, Bullerdiek J (1999). A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer 26:125-133.

  • Polito P, Dal Cin P, Kazmierczak B, Rogalla P, Bullerdiek J, Van den Berghe H (1999). Deletion of HMG17 in uterine leiomyomas with ring chromosome 1. Cancer Genet Cytogenet 108:107-109.

  • Reimann N, Bartnitzke S, Nolte I, Bullerdiek J (1999). Working with canine chromosomes: current recommendations for karyotype description. J Hered 90:31-34.

  • Reimann N, Nolte I, Bartnitzke S, Bullerdiek J (1999). Re: Sit, DNA, sit: cancer genetics going to the dogs. J Natl Cancer Inst 91:1688-1689.

  • Reimann N, Nolte I, Bonk U, Bartnitzke S, Bullerdiek J (1999). Cytogenetic investigation of canine lipomas. Cancer Genet Cytogenet 111:172-174.

  • Rippe V, Belge G, Meiboom M, Kazmierczak B, Fusco A, Bullerdiek J (1999). A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors. Genes Chromosomes Cancer 26:229-236.

  • Rohen C, Rogalla P, Meyer-Bolte K, Bartnitzke S, Chilla R, Bullerdiek J (1999). Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements. Cancer Genet Cytogenet 111:178-181.

1998
  • Belge G, Roque L, Soares J, Bruckmann S, Thode B, Fonseca E, Clode A, Bartnitzke S, Castedo S, Bullerdiek J (1998). Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 101:42-48.

  • Belge G, Roque L, Thode B, Fonseca E, Soares J, Clode A, Bartnitzke S, Castedo S, Bullerdiek J (1997). Zytogenetische Veränderungen bei benignen Schilddrüsenhyperplasien und Adenomen korrelieren mit der Histologie. Verh Dtsch Ges Pathol 81:151-156.

  • Dal Cin P, Timmerman D, Van den Berghe I, Wanschura S, Kazmierczak B, Vergote I, Deprest J, Neven P, Moerman P, Bullerdiek J, Van den Berghe H (1998). Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen. Cancer Res 58:2278-2281.

  • Dal Cin P, Wanschura S, Kazmierczak B, Tallini G, Dei Tos A, Bullerdiek J, Van den Berghe I, Moerman P, Van den Berghe H (1998). Amplification and expression of the HMGIC gene in a benign endometrial polyp. Genes Chromosomes Cancer 22:95-99.

  • Fedele M, Berlingieri MT, Scala S, Chiariotti L, Viglietto G, Rippe V, Bullerdiek J, Santoro M, Fusco A (1998).  Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 17:413-418.

  • Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J, Hameister H (1998). The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 23:350-357.

  • Hörsting N, von Reiswitz A, Wohlsein P, Bullerdiek J, Reimann N, Nolte I (1998). Oropharyngeale Tumoren des Hundes - eine klinische Studie über 79 Fälle. Berl Münch Tierarztl Wochenschr 111:242-247.

  • Jox A, Taquia E, Vockerodt M, Draube A, Pawlita M, Möller P, Bullerdiek J, Diehl V, Wolf J (1998). Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Cancer Res 58:4930-4939.

  • Kazmierczak B, Bullerdiek J, Pham KH, Bartnitzke S, Wiesner H (1998). Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years. Cancer Genet Cytogenet 103:175-177.

  • Kazmierczak B, Dal Cin P, Wanschura S, Bartnitzke S, Van den Berghe H, Bullerdiek J (1998). Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors. Am J Pathol 152:431-435.

  • Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, Bullerdiek J (1998). HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 23:279-285.

  • Reimann N, Bartnitzke S, Bullerdiek J, Mischke R, Nolte I (1998). Trisomy 1 in a canine acute leukemia indicating the pathogenetic importance of polysomy 1 in leukemias of the dog. Cancer Genet Cytogenet 101:49-52.

  • Rogalla P, Borda Z, Meyer-Bolte K, Tran KH, Hauke S, Nimzyk R, Bullerdiek J (1998). Mapping and molecular characterization of five HMG1-related DNA sequences. Cytogenet Cell Genet 83:124-129.

  • Rogalla P, Borda Z, Meyer-Bolte K, Tran KH, Hauke S, Nimzyk R, Bullerdiek J (1998). Mapping and molecular characterization of five HMG1-related DNA sequences. Cytogenet Cell Genet 83:124-129.

  • Rogalla P, Drechsler K, Schröder-Babo W, Eberhardt K, Bullerdiek J (1998). HMGIC expression patterns in non-small lung cancer and surrounding tissue. Anticancer Res 18:3327-3330.

  • Rogalla P, Kazmierczak B, Meyer-Bolte K, Tran KH, Bullerdiek J (1998). The t(3;12)(q27;q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype. Genes Chromosomes Cancer 22:100-104.

  • Roque L, Clode A, Belge G, Pinto A, Bartnitzke S, Santos JR, Thode B, Bullerdiek J, Castedo S, Soares J (1998). Follicular thyroid carcinoma: chromosome analysis of 19 cases. Genes Chromosomes Cancer 21:250-255.

  • Staats B, Bonk U, Gohla G, Bartnitzke S, Bullerdiek J (1998). Two cases of fibrocystic breast disease with polysomy 18 as the sole clonal cytogenetic abnormality. Cancer Genet Cytogenet 103:91-94.

1997
  • Belge G, Caselitz J, Bonk U, Bartnitzke S, Bullerdiek J (1997). Genetische Untersuchungen zur Differentialdiagnose von Fettgewebstumoren. Pathologe 18:160-166.

  • Belge G, Garcia E, Rippe V, Fusco A, Bartnitzke S, Bullerdiek J (1997). Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region. Genes Chromosomes Cancer 20:201-203.

  • Belge G, Roque L, Thode B, Fonseca E, Soares J, Clode A, Bartnitzke S, Castedo S, Bullerdiek J (1997). Zytogenetische Veränderungen bei benignen Schilddrüsenhyperplasien und Adenomen korrelieren mit der Histologie. Verh. Dtsch. Ges. Pathol. 81: 151-156.

  • Dal Cin P, Wanschura S, Christiaens MR, Van den Berghe I, Moerman P, Polito P, Kazmierczak B, Bullerdiek J, Van Den Berghe H (1997). Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY. Genes Chromosomes Cancer 20:90-92.

  • Hennig Y, Caselitz J, Bartnitzke S, Bullerdiek J (1997). A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 -21;q11.2-21). Cancer Genet Cytogenet 98:84-86.

  • Hennig Y, Rogalla P, Wanschura S, Frey G, Deichert U , Bartnitzke S, Bullerdiek J (1997). HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality. Cancer Genet Cytogenet 96:129-133.

  • Jox A, Rohen C, Belge G, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J, Wolf J (1997). Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability. Ann Oncol 8 Suppl 2:131-135.

  • Nolte I, Reimann N, Bullerdiek J, Bartnitzke S, Mischke R, Nolte M (1997). Die Bedeutung zytogenetischer Untersuchungen bei Leukämien des Hundes. Tierarztl Prax 25:393-397.

  • Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, Bullerdiek J (1997). Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog 19:153-156.

  • Rommel B, Rogalla P, Jox A, Kalle CV, Kazmierczak B, Wolf J, Bullerdiek J (1997). HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma 26:603-607.

  • Vanni R, Marras S, Schoenmakers EF, Dal Cin P, Kazmierczak B, Senger G, Bullerdiek J, Van de Ven WJ, Van Den Berghe H (1997). Molecular cytogenetic characterization of del(7q) in two uterine leiomyoma-derived cell lines. Genes Chromosomes Cancer 18:155-161.

  • Wanschura S, Dal Cin P, Kazmierczak B, Bartnitzke S, Van den Berghe H, Bullerdiek J (1997). Hidden paracentric inversions of chromosome arm 12q affecting the HMGIC gene. Genes Chromosomes Cancer 18:322-323.

  • Wanschura S, Kazmierczak B, Bonk U, Bartnitzke S, Bullerdiek J (1997). Rearrangierungen des HMGIC Gens in benignen mesenchymalen Tumoren mit Veränderungen der chromosomalen Region 12q14-15. Verh Dtsch Ges Path 81:607.

1996
  • Belge G, Bruckmann S, Thode B, Bartnitzke S, Bullerdiek J (1996). Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors. Genes Chromosomes Cancer 16:149-151.

  • Bol S, Wanschura S, Thode B, Deichert U, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1996). An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet 90:88-90.

  • Hennig Y, Deichert U, Stern C, Ghassemi A, Thode B, Bonk U, Meister P, Bartnitzke S, Bullerdiek J (1996). Structural aberrations of chromosome 6 in three uterine smooth muscle tumors . Cancer Genet Cytogenet 87:148-151.

  • Hennig Y, Wanschura S, Deichert U, Bartnitzke S, Bullerdiek J (1996). Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps. Mol Hum Reprod 2:277-283.

  • Kazmierczak B, Bol S, Wanschura S, Bartnitzke S, Bullerdiek J (1996). PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes Chromosomes Cancer 17:191-193.

  • Kazmierczak B, Pohnke Y, Bullerdiek J (1996). Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics 38:223-226.

  • Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJ, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S , Bullerdiek J (1996). HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 12:515-521.

  • Kazmierczak B, Wanschura S, Rommel B, Bartnitzke S, Bullerdiek J (1996). Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings. J Natl Cancer Inst 88:1234-1236.

  • Leuschner E, Staats B, Gohla G, Bartnitzke S, Bonk U , Bullerdiek J (1996). Fluorescence in situ hybridization studies on breast tumor samples for distinguishing between different subsets of breast cancer. Acta Cytol 40:151-157.

  • Reimann N, Bartnitzke S, Bullerdiek J, Schmitz U, Rogalla P, Nolte I, Ronne M (1996). An extended nomenclature of the canine karyotype. Cytogenet Cell Genet 73:140-144.

  • Reimann N, Nolte I, Bonk U, Werner M, Bullerdiek J, Bartnitzke S (1996). Trisomy 18 in a canine thyroid adenoma. Cancer Genet Cytogenet 90:154-156.

  • Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J (1996). HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 149:775-779.

  • Rogalla P, Rohen C, Bonk U, Bullerdiek J (1996). Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers. Cancer Lett 106:155-161.

  • Rohen C, Staats B, Bonk U, Bartnitzke S, Bullerdiek J (1996). Significance of clonal chromosome aberrations in breast fibroadenomas. Cancer Genet Cytogenet 87:152-155.

  • Rohen G, Bartnitzke S, Bullerdiek J, Bonk U (1996). Trisomy 8 and 20 in desmoid tumors and breast cancer: more than a casual coincidence? Cancer Genet Cytogenet 86:92.

  • Roijer E, Kas K, Klawitz I, Bullerdiek J, Van de Ven W, Stenman G (1996). Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12). Genes Chromosomes Cancer 17:166-171.

  • Staats B, Bonk U, Wanschura S, Hanisch P, Schoenmakers EF, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1996). A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 38:299-303.

  • Wanschura S, Belge G, Stenman G, Kools P, Dal Cin P, Schoenmakers E, Huysmans C, Van den Berghe H, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1996). Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12. Cancer Genet Cytogenet 86:39-45.

  • Wanschura S, Kazmierczak B, Bartnitzke S, Bullerdiek J, Schloot W, Schoenmakers E, Meyen E, Van de Ven W (1996). Molecular cytogenetic assignment of the chromosome 12 breakpoints in many benign tumors to 12q15 affecting the HMGIC gene. Genes Chromosomes Cancer 15:195-196.

  • Wanschura S, Kazmierczak B, Pohnke Y, Meyer-Bolte K, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1996). Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality. Cancer Lett 102:17-21.

  • Wanschura S, Schoenmakers EF, Huysmans C, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1996). Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25. Genomics 32:298-300.

  • Wanschura S, Schoenmakers EFPM, Huysmans C, Bartnitzke S, Van de Ven WJM, Bullerdiek J (1996). Mapping of the human HMG2 gene to 4q31. Genomics 31:264-265.

1995
  • Belge G, Garcia E, de Jong P, Bartnitzke S, Bullerdiek J (1995). FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4. Cytogenet Cell Genet 69:220-222.

  • Dürst M, Seagon S, Wanschura S, zur Hausen H, Bullerdiek J (1995). Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro. Cancer Genet Cytogenet 85:105-112.

  • Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W, Bullerdiek J (1995). Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 55:6038-6039.

  • Kazmierczak B, Stern C, Bartnitzke S, Bullerdiek J (1995). Non-random jumping translocations as a result of SV40 large T-antigen expression in benign human tumor cells. Cell Biol Int 19:315-322.

  • Kazmierczak B, Wanschura S, Meyer-Bolte K, Caselitz J, Meister P, Bartnitzke S, Van de Ven W, Bullerdiek J (1995). Cytogenic and molecular analysis of an aggressive angiomyxoma. Am J Pathol 147:580-585.

  • Kazmierczak B, Wanschura S, Rosigkeit J, Meyer-Bolte K, Uschinsky K, Haupt R, Schoenmakers EF, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1995). Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas. Cancer Res 55:2497-2499.

  • Kools PF, Wanschura S, Schoenmakers EF, Geurts JM, Mols R, Kazmierczak B, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1995). Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality. Cancer Genet Cytogenet 79:1-7.

  • Rogalla P, Rohen C, Hennig Y, Deichert U, Bonk U, Bullerdiek J (1995). Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas. Biochem Biophys Res Commun 211:175-182.

  • Rohen C, Caselitz J, Stern C, Wanschura S, Schoenmakers EF, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1995). A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization. Cancer Genet Cytogenet 84:82-84.

  • Rohen C, Meyer-Bolte K, Bonk U, Ebel T, Staats B, Leuschner E, Gohla G, Caselitz J, Bartnitzke S, Bullerdiek J (1995). Trisomy 8 and 18 as frequent clonal and single-cell aberrations in 185 primary breast carcinomas. Cancer Genet Cytogenet 80:33-39.

  • Schoenmakers EF, Geurts JM, Kools PF, Mols R, Huysmans C, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1995). A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors. Genomics 29:665-678.

  • Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1995). Recurrent rearrangements in the high mobility group protein gene, HMGI- C, in benign mesenchymal tumours. Nat Genet 10:436-444.

  • Van de Ven WJ, Schoenmakers EF, Wanschura S, Kazmierczak B, Kools PF, Geurts JM, Bartnitzke S, Van den Berghe H, Bullerdiek J (1995). Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chromosomes Cancer 12:296-303.

  • Wanschura S, Hennig Y, Deichert U, Schoenmakers EF, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1995). Molecular-cytogenetic refinement of the 12q14-->q15 breakpoint region affected in uterine leiomyomas. Cytogenet Cell Genet 71:131-135.

  • Wanschura S, Kazmierczak B, Schoenmakers E, Meyen E, Bartnitzke S, Van de Ven W, Bullerdiek J, Schloot W (1995). Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15. Genes Chromosomes Cancer 14:68-70.

  • Wolf J, Jox A, Skarbek H, Pukrop T, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J (1995). Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site. Virology 212:179-185.

1994
  • Belge G, Thode B, Bartnitzke S, Bullerdiek J (1994). Cytogenetic biclonality corresponding to multiphasic differentiation in an atypical thyroid adenoma. Cancer Genet Cytogenet 78:102-104.

  • Belge G, Thode B, Rippe V, Bartnitzke S, Bullerdiek J (1994). A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet 94:198-202.

  • Bullerdiek J, Bonk U, Staats B, Leuschner E, Gohla G , Ebel T, Bartnitzke S (1994). Trisomy 18 as the first chromosome abnormality in a medullary breast cancer. Cancer Genet Cytogenet 73:75-78.

  • Franke S, Klawitz I, Schnakenberg E, Rommel B, Van de Ven W, Bullerdiek J, Schloot W (1994). Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochem Biophys Res Commun 199:52-55.

  • Kapp U, Dux A, Schell-Frederick E, Banik N, Hummel M , Mucke S, Fonatsch C, Bullerdiek J, Gottstein C, Engert A, Diehl V, Wolf J (1994). Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID mice. Ann Oncol 5 Suppl 1:121-126.

  • Kools PF, Roebroek AJ, Van de Velde HJ, Marynen P, Bullerdiek J, Van de Ven WJ (1994). Regional mapping of the human NSP gene to chromosome region 14q21-->q22 by fluorescence in situ hybridization analysis. Cytogenet Cell Genet 66:48-50.

  • Leuschner E, Meyer-Bolte K, Caselitz J, Bartnitzke S, Bullerdiek J (1994). Fibroadenoma of the breast showing a translocation (6;14), a ring chromosome and two markers involving parts of chromosome 11. Cancer Genet Cytogenet 76:145-147.

  • Reimann N, Rogalla P, Kazmierczak B, Bonk U, Nolte I , Grzonka T, Bartnitzke S, Bullerdiek J (1994). Evidence that metacentric and submetacentric chromosomes in canine tumors can result from telomeric fusions. Cytogenet Cell Genet 67:81-85.

  • Rogalla P, Kazmierczak B, Rohen C, Trams G, Bartnitzke S, Bullerdiek J (1994). Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging. Cancer Genet Cytogenet 77:19-25.

  • Schoenmakers EF, Kools PF, Mols R, Kazmierczak B, Bartnitzke S, Bullerdiek J, Dal Cin P, De Jong PJ, Van den Berghe H, Van de Ven WJ (1994). Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma. Genomics 20:210-222.

  • Schoenmakers EF, Mols R, Wanschura S, Kools PF, Geurts JM, Bartnitzke S, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1994). Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas. Genes Chromosomes Cancer 11:106-118.

1993
  • Bullerdiek J, Leuschner E, Taquia E, Bonk U, Bartnitzke S (1993). Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet Cytogenet 65:64-67.

  • Bullerdiek J, Wobst G, Meyer-Bolte K, Chilla R, Haubrich J, Thode B, Bartnitzke S (1993). Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 65:27-31.

  • Delecluse HJ, Bartnizke S, Hammerschmidt W, Bullerdiek J, Bornkamm GW (1993). Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J Virol 67:1292-1299.

  • Lotz S, Caselitz J, Bullerdiek J, Rieckhoff KU (1993). Monophasisch fibröses Synovialsarkom der Hand mit biphasisch differenzierten Lungenmetastasen. Pathologe 14:54-57.

  • Rohen C, Bonk U, Staats B, Bartnitzke S, Bullerdiek J (1993). Two human breast tumors with translocations involving 12q13-15 as the sole cytogenetic abnormality. Cancer Genet Cytogenet 69:68-71.

  • Schoenmakers HF, Kools PF, Kazmierczak B, Bullerdiek J, Claussen U, Horsthemke B, Van den Berghe H, Van de Ven WJ (1993). Isolation of a somatic cell hybrid retaining the der(16)t(12;16)(q13;p11.2) from a myxoid liposarcoma cell line. Cytogenet Cell Genet 62:159-161.

  • Wolf J, Pawlita M, Jox A, Kohls S, Bartnitzke S, Diehl V, Bullerdiek J (1993). Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line. Cancer Genet Cytogenet 67:90-94.

1992
  • Bartnitzke S, Motzko H, Caselitz J, Kornberg M, Bullerdiek J, Schloot W (1992). A recurrent marker chromosome involving chromosome 1 in two mammary tumors of the dog. Cytogenet Cell Genet 60:135-137.

  • Bartnitzke S, Motzko H, Rosenhagen C, Bullerdiek J (1992). Benign mixed tumor of canine mammary gland showing an r(X) and trisomy 5 as the only clonal abnormalities. Cancer Genet Cytogenet 62:29-31.

  • Bartnitzke S, Skarbek H, Lackmann C, Bullerdiek J (1992). Chang medium raises the chromatin instability of pericentromeric areas of chromosome 1 in amniotic fluid cells. Prenat Diagn 12:310-311.

  • Belge G, Kazmierczak B, Meyer-Bolte K, Bartnitzke S, Bullerdiek J (1992). Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation t(3;12) is not sufficient for direct immortalization. Cell Biol Int Rep 16:339-347.

  • Belge G, Thode B, Bullerdiek J, Bartnitzke S (1992). Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas? Cancer Genet Cytogenet 60:23-26.

  • Delecluse HJ, Kohls S, Bullerdiek J, Bornkamm GW (1992). Integration of EBV in Burkitt's lymphoma cells." Curr Top Microbiol Immunol 182:367-373.

  • Kazmierczak B, Thode B, Bartnitzke S, Bullerdiek J, Schloot W (1992). Pleomorphic adenoma cells vary in their susceptibility to SV40 transformation depending on the initial karyotype. Genes Chromosomes Cancer 5:35-39.

  • Stern C, Deichert U, Thode B, Bartnitzke S, Bullerdiek J (1992). Eine zytogenetische Subtypisierung von 139 Uterus-Leiomyomen. Geburtshilfe Frauenheilkd 52:767-772.

1991
  • Belge G, Thode B, Bullerdiek J, Bartnitzke S (1991). Deletion of part of the long arm of chromosome 13 as the only karyotypic aberration in a follicular thyroid adenoma. Cancer Genet Cytogenet 56:277-280.

  • Bullerdiek J, Bartnitzke S (1991). Chromosomal abnormalities in pleomorphic adenomas. Related to origin or karyotypic evolution? Cancer Genet Cytogenet 53:283-284.

  • Chen G, Hutter KJ, Bullerdiek J, Zeller WJ (1991). Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell line. J Cancer Res Clin Oncol 117:539-542.

  • Rommel B, de Villiers EM, Durst M, Bartnitzke S, Bullerdiek J (1991). Failure to detect human papillomavirus sequences at the 3p21 rearrangement site in pleomorphic adenomas. Cancer Genet Cytogenet 52:187-191.

  • Stern C, Kazmierczak B, Thode B, Rommel B, Bartnitzke S, Dal Cin P, Van de Ven, Van den Berghe H, Bullerdiek J (1991). Leiomyoma cells with 12q15 aberrations can be transformed in vitro and show a relatively stable karyotype during precrisis period. Cancer Genet Cytogenet 54:223-228.

1990
  • Bartnitzke S, Eberhardt D, Krooss J, Rommel B, Bullerdiek J (1990). In situ nick translation of human chromosomes using Alu I: unmasking of recognition sites by proteinase K pretreatment. Cytobios 62:93-99.

  • Bullerdiek J, Hutter KJ, Brandt G, Weinberg M, Belge G, Bartnitzke S (1990). Cytogenetic investigations on a cell line derived from a carcinoma arising in a salivary gland pleomorphic adenoma. Cancer Genet Cytogenet 44:253-262.

  • Bullerdiek J, Vollrath M, Wittekind C, Caselitz J, Bartnitzke S (1990). Mucoepidermoid tumor of the parotid gland showing a translocation (3;8)(p21;q12) and a deletion (5)(q22) as sole chromosome abnormalities. Cancer Genet Cytogenet 50:161-164.

  • Kazmierczak B, Bartnitzke S, Hartl M, Bullerdiek J (1990). In vitro transformation by the SV40 'early region' of cells from a human benign salivary gland tumor with a 12q13----q15 rearrangement. Cytogenet Cell Genet 53:37-39.

  • Rommel B, Bullerdiek J, Bartnitzke S, Schloot W (1990). No rearrangement of c-mos in salivary gland pleomorphic adenomas with 8q12 aberrations. Cancer Genet Cytogenet 49:165-169.

  • Stern C, Meyer K, Bartnitzke S, Schloot W, Bullerdiek J (1990). Pleomorphic adenomas with unbalanced chromosomal abnormalities have an increased in vitro lifetime. Cancer Genet Cytogenet 46:55-63.

  • Wolf J, Pawlita M, Bullerdiek J, zur Hausen H (1990). Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Cancer Res 50:3095-3100.

  • Wolf J, Pawlita M, Bullerdiek J, zur Hausen H (1990). Deregulated c-myc gene expression and persistence of EBV are not sufficient to maintain the malignant phenotype in Burkitt's lymphoma x B-lymphoblastoid hybrid cells. Curr Top Microbiol Immunol 166:333-336.

1979 - 1989
  • Bartnitzke S, Herrmann ME, Lobeck H, Zuschneid W, Neuhaus P, Bullerdiek J (1989). Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19). Cancer Genet Cytogenet 39:65-68.

  • Bullerdiek J, Takla G, Bartnitzke S, Brandt G, Chilla R, Haubrich J (1989). Relationship of cytogenetic subtypes of salivary gland pleomorphic adenomas with patient age and histologic type. Cancer 64:876-880.

  • Wolf J, Pawlita M, Bullerdiek J, zur Hausen H (1989). Establishment of a hybrid cell system between malignant Burkitt's lymphoma cells and nonmalignant lymphoblastoid cells. Hamatol Bluttransfus 32:220-222.

  • Bullerdiek J, Chilla R, Haubrich J, Meyer K, Bartnitzke S (1988). A causal relationship between chromosomal rearrangements and the genesis of salivary gland pleomorphic adenomas. Arch Otorhinolaryngol 245:244-249.

  • Bullerdiek J, Haubrich J, Meyer K, Bartnitzke S (1988). Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet Cytogenet 35:129-132.

  • Rommel B, Hutter KJ, Bullerdiek J, Bartnitzke S, Goerttler K, Schloot W (1988). Identification of flow-sorted chromosomes by G-banding and in situ hybridization. Cytometry 9:504-507.

  • Bullerdiek J, Bartnitzke S, Weinberg M, Chilla R, Haubrich J, Schloot W (1987). Rearrangements of chromosome region 12q13----q15 in pleomorphic adenomas of the human salivary gland (PSA). Cytogenet Cell Genet 45:187-190.

  • Bullerdiek J, Böschen C, Bartnitzke S (1987). Aberrations of chromosome 8 in mixed salivary gland tumors--cytogenetic findings on seven cases. Cancer Genet Cytogenet 24:205-212.

  • Bullerdiek J, Raabe G, Bartnitzke S, Boschen C, Schloot W (1987). Structural rearrangements of chromosome Nr 8 involving 8q12--a primary event in pleomorphic ademona of the parotid gland. Genetica 72:85-92.

  • Bullerdiek J, Raabe G, Boschen C, Bartnitzke S (1987). Translocation (3;8;8)(p22 or p23;p23;q12) in a case of pleomorphic adenoma: similarity to a primary cytogenetic abnormality detected in an endometrial adenocarcinoma. Cancer Genet Cytogenet 27:177-180.

  • Bullerdiek J, Dittmer J, Faehre A, Bartnitzke S (1986). An improved method for in situ nick translation of human chromosomes with biotin 11-labelled dUTP detected by biotinylated alkaline phosphatase. Cytobios 45:35-43.

  • Bullerdiek J, Dittmer J, Faehre A, Bartnitzke S (1986). Mechanisms of in situ nick translation of chromosomes using restriction endonucleases. Cytobios 47:33-44.

  • Djalali M, Steinbach P, Bullerdiek J, Holmes-Siedle M, Verschraegen-Spae MR, Smith A (1986). The significance of pericentric inversions of chromosome 2. Hum Genet 72:32-36.

  • Bullerdiek J, Bartnitzke S, Kahrs E, Schloot W (1985). Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome. Cytobios 42:15-24.

  • Bullerdiek J, Bartnitzke S, Kahrs E, Schloot W (1985). Further evidence for nonrandom chromosome changes in carcinoma cells--a report of 28 cases. Cancer Genet Cytogenet 16:33-43.

  • Bullerdiek J, Bartnitzke S, Lamprecht G (1985). A computer program for the simulation of colony-like proliferation of fibroblasts and their cell cycle behavior. Comput Methods Programs Biomed 20:95-100.

  • Bullerdiek J, Bartnitzke S (1985). The deleted long arm of chromosome 6: a secondary chromosome abnormality in solid tumors and lack of congenital aberrations monosomic for part of the critical segment? Cancer Genet Cytogenet 18:183-185.

  • Bullerdiek J, Dittmer J, Faehre A, Bartnitzke S, Kasche V, Schloot W (1985). A new banding pattern of human chromosomes by in situ nick translation using ECO RI and biotin-dUTP. Clin Genet 28:173-176.

  • Bullerdiek J, Heyat M, Bartnitzke S, Claussen U, Schloot W (1985). The pipette-method: its application to cytogenetic studies of tumor cells cloned in semisolid media. Anticancer Res 5:411-413.

  • Bullerdiek J, Bartnitzke S, Pahlke R (1984). Perizentrische Inversion des Y-Cchromosoms als Ausschlusskonstellation. Anthropol Anz 42:67-72.

  • Bullerdiek J, Bartnitzke S, Schloot W (1983). Cells with double minutes divided into two categories. Cancer Genet Cytogenet 9:301-304.

  • Bartnitzke S, Bullerdiek J, Wuestenberg B, Schloot W (1982). In vitro selection of tumor cells obtained from patients with ovarian carcinoma. A cytogenetic study. Anticancer Res 2:75-78.

  • Bullerdiek J, Bartnitzke S (1982). Die Bedeutung der menschlichen Zytogenetik für Untersuchungen zur Evolution der Hominiden. Anthropol Anz 40:81-89.

  • Bullerdiek J, Bartnitzke S (1982). Hypotonic treatment in visual and automatic chromosome analysis. Clin Genet 22:150.

  • Bartnitzke S, Bullerdiek J, Schloot W (1981). Effects of hypotonic treatment on human metaphase chromosome length. Cytobios 31:75-80.

  • Bullerdiek J, Bartnitzke S, Schloot W (1979). A rapid and simple sandwich-method used for chromosome analysis from small fetal and adult biopsy specimens. Clin Genet 16:433-437.








Top